Kraaijvanger R, Veltkamp M
Microorganisms. 2022; 10(8).
PMID: 36014067
PMC: 9415339.
DOI: 10.3390/microorganisms10081649.
Corvec S
Clin Microbiol Rev. 2018; 31(3).
PMID: 29848774
PMC: 6056840.
DOI: 10.1128/CMR.00064-17.
Buck G, Kelly M
Infect Immun. 1980; 27(2):620-7.
PMID: 7380542
PMC: 550809.
DOI: 10.1128/iai.27.2.620-627.1980.
Nakayama S, Nakamura S, Yoshinaga M
Immunology. 1982; 45(4):669-77.
PMID: 7040213
PMC: 1555409.
Badmajew W, Jakoniuk P, Borowski J
Experientia. 1980; 36(11):1321-3.
PMID: 7004887
DOI: 10.1007/BF01969613.
Immune-complex disease in mice and humans given C. parvum.
Mitcheson H, Uff J, Pussell B, Brill M, Castro J
Br J Cancer. 1980; 42(1):34-40.
PMID: 6448615
PMC: 2010474.
DOI: 10.1038/bjc.1980.200.
Vaccines and cell-mediated immunity.
Collins F
Bacteriol Rev. 1974; 38(4):371-402.
PMID: 4613342
PMC: 413869.
DOI: 10.1128/br.38.4.371-402.1974.
Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.
Collins F, Scott M
Infect Immun. 1974; 9(5):863-9.
PMID: 4596278
PMC: 414899.
DOI: 10.1128/iai.9.5.863-869.1974.
Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum.
Warr G, Sljivic V
Clin Exp Immunol. 1974; 17(3):519-32.
PMID: 4157122
PMC: 1554075.
Activity of the reticuloendothelial system and the antibody response. III. The fate of type III pneumococcal polysaccharide and the antibody response.
Sljivic V, Warr G
Immunology. 1974; 27(6):1009-22.
PMID: 4156026
PMC: 1445702.
Corynebacterium parvum augments antibody production in splenectomized mice and mice with sham operations.
Hebert J, Ershler W, Gamelli R
Infect Immun. 1985; 48(3):795-8.
PMID: 3997248
PMC: 261266.
DOI: 10.1128/iai.48.3.795-798.1985.
Antitumour effect of corynebacterium parvum. Possible mode of action.
Baum M, Breese M
Br J Cancer. 1976; 33(4):468-73.
PMID: 1268035
PMC: 2025090.
DOI: 10.1038/bjc.1976.73.
Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.
Wiener E, Bandieri A
Immunology. 1975; 29(2):265-74.
PMID: 1158386
PMC: 1445948.
Suppression of the immune response by microorganisms.
Schwab J
Bacteriol Rev. 1975; 39(2):121-43.
PMID: 1095003
PMC: 413897.
DOI: 10.1128/br.39.2.121-143.1975.
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
Warr G, JAMES K
Immunology. 1975; 28(3):431-42.
PMID: 1092609
PMC: 1445794.
Pathogenesis of Salmonella-associated arithritis in the rat.
VOLKMAN A, Collins F
Infect Immun. 1975; 11(2):222-30.
PMID: 1089597
PMC: 415049.
DOI: 10.1128/iai.11.2.222-230.1975.
Mitogenicity of Corynebacterium parvum for mouse lymphocytes.
Zola H
Clin Exp Immunol. 1975; 22(3):514-21.
PMID: 817854
PMC: 1538433.
Immunocompetent cells in resistance to bacterial infections.
Campbell P
Bacteriol Rev. 1976; 40(2):284-313.
PMID: 786253
PMC: 413959.
DOI: 10.1128/br.40.2.284-313.1976.
Enhancement of tissue invasion in murine aspergillosis by systemic administration of suspensions of killed Corynebacterium parvum.
Purnell D
Am J Pathol. 1976; 83(3):547-56.
PMID: 779492
PMC: 2032499.
The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
Watson S, Sljivic V
Clin Exp Immunol. 1976; 23(1):149-53.
PMID: 770033
PMC: 1538357.
